mercredi 23 novembre 2016

Onco Actu du 23 novembre 2016

3.1 Tabac

Australia’s plain cigarette packs are ‘putting teens off smoking’ [Cancer Research UK]

4. Dépistage, diagnostic et pronostic

UK’s pathology services at tipping point [Cancer Research UK]

Device Uses Cancer Cells' Mass to Predict Response to Treatment [NCI]

NHS cancer testing service 'at breaking point' [BBC News]

NHS 'struggling to cope' with increase in people undergoing cancer tests [The Guardian]

5. Traitements

New era in cancer treatment to begin as Sadiq Khan opens revolutionary radiotherapy machine [Institute of Cancer Research]

Restoring leaky blood vessels could lead to new cancer treatment [Cancer Research UK]

5.2 Pharma

FDA lifts PD-L1 hold on AstraZeneca head and neck cancer test [FierceBiotech]

After a painful stumble, AstraZeneca gets top checkpoint cancer program back on track [EndPoints]

5.2.3 Pharma - économie

Nonadherence costs pharma $600B-plus in annual sales: study [FiercePharma]

5.3 Traitements - FDA, EMA, NICE...

Could the FDA be dismantled under Trump? [STAT]

5.3.4 Traitements - AMM (FDA, EMA)

European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for the Treatment of Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant and Treatment With Brentuximab Vedotin [BMS]

5.4 Traitements - Economie

Precision medicine will increase drug prices and that’s a good thing [MedCity News]

5.8.1 ASH - Communiqués

New KEYTRUDA® (pembrolizumab) Data in Blood Cancers to be Presented at 58th Annual Meeting of the American Society of Hematology [Merck]

Nearly 350 Abstracts Evaluating Celgene Therapies to Be Presented at American Society of Hematology Annual Meeting (ASH) [Celgene]

6. Lutte contre les cancers

William Sellers appointed to faculty at Broad Institute, Dana-Farber Cancer Institute, and Harvard Medical School [Broad Institute]

6.1 Observation

Palliative care linked to better, if not longer, life [Reuters]

6.10.1 Politiques (USA)

Precision Medicine In Trump Era? California Presses Own Modest Program [Xconomy]

As Trump prepares for office, Biden’s ‘moonshot’ against cancer hangs in the balance [STAT]

US Cancer Moonshot must strike a balance between research and prevention [Nature]